Plain-English translation of NCT07205341 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a small pilot study testing a device called HemoCept that monitors your blood volume and how well your heart is working during aortic valve replacement surgery. The goal is to see whether the device can accurately detect changes in these measurements during the procedure. If successful, this device could help doctors better manage patients during heart surgery.
During heart valve replacement surgery, doctors need to closely monitor how much blood is in your arteries and how efficiently your heart is pumping. This new monitoring device may provide better real-time information to help surgeons and anesthesiologists make safer decisions during the operation.
You likely qualify if…
You likely don't qualify if…
If you join this study, the HemoCept monitoring device will be used alongside your scheduled aortic valve replacement surgery—you won't need extra procedures. Researchers will collect data from the device during your operation to see how well it tracks your blood volume and heart function. The study involves about 20 participants total, and your participation centers around your surgery and standard post-operative care.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
United States
Enrollment target
~20 participants
Started
April 2025
Primary completion
September 2026
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Katharine Adkins
Boulder Heart
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.